Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine

Tony Kendrick(University of Southampton), Christopher Thompson(Royal South Hants Hospital), Helen Smith(University of York), Louise Longworth(Bielefeld University), Michael Moore(Indiana University School of Medicine), Andrew Thornett, Robert Peveler(University of Southampton), Judy Chatwin, David S. Baldwin(University of Southampton), Jonathan Goddard(Southampton General Hospital), Martin Buxton(Brunel University of London), Michael J. Campbell(University of Sheffield)
The British Journal of Psychiatry
April 1, 2006
Cited by 42


Related Papers